CClinicalTrials.gg
CompletedNCT00950053Updated Mar 13, 2013

Chronic Insertional Achilles Tendonitis Treated With or Without Flexor Hallucis Longus Tendon Transfer

A Phase 4 interventional study of Achilles decompression & debridement and Achilles decompression and debridement with FHL transfer in Chronic Insertional Achilles Tendonitis, sponsored by OrthoCarolina Research Institute, Inc.. Completed at 1 site in United States. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2013-03-13.

Sponsored by OrthoCarolina Research Institute, Inc. · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine whether Achilles tendon debridement and decompression augmented with flexor hallucis longus (FHL) tendon transfer results in improved clinical and functional outcome as measured by ankle plantar flexion strength and American Orthopedic Foot and Ankle Society (AOFAS) score compared to debridement and decompression alone in patients over 50 years of age with chronic insertional Achilles tendinosis.

H0: There will be no difference in ankle plantar flexion strength measured using a handheld dynamometer between patients randomized to achilles tendon decompression and debridement alone (Group 1) and patients randomized to achilles tendon decompression and debridement augmented with FHL transfer (Group 2).

HA: Patients randomized to achilles tendon decompression and debridement alone (Group 1) will have less ankle plantar flexion strength compared to patients randomized to achilles tendon decompression and debridement augmented with FHL transfer (Group 2).

02

Conditions studied

  • Chronic Insertional Achilles Tendonitis
03

In context

Tendinopathy

413 studies on the registry are indexed under Tendinopathy; 64 are open to participants now.

This study's enrollment of 52 is close to the median of 50 across 339 interventional studies indexed under Tendinopathy.

Browse Tendinopathy studies →

Lead sponsor

OrthoCarolina Research Institute, Inc. is the lead sponsor of 34 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients 50 years of age or older
  • Patients diagnosed with chronic insertional Achilles tendonitis
  • Failed greater than 3 months of conservative treatment (activity and shoe modification, heel lifts, non-steroidal anti-inflammatory medications, stretching exercises, and formal physical therapy)

Exclusion criteria

Exclusion Criteria:

  • Patients less than 50 years of age upon presentation
  • Females of child-bearing potential
  • Patients who have a history of ipsilateral Achilles tendon rupture
  • History of infection in the same lower extremity
  • Patients unable to undergo MRI scan
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
52 participants (actual)

Study arms

  • Active comparator
    Achilles decompression & debridement

    Procedure: Achilles decompression & debridement

  • Active comparator
    Achilles decompression,debride&FHLtransf

    Achilles tendon decompression and debridement augmented with FHL transfer. The preferred skin incision will be followed by central-splitting Achilles debridement, resection of a Haglund's lesion if present and pathologic, followed by FHL harvest for patients in group 2. The fixation technique in group 2 will utilize an interference screw for the FHL. For all patients, the Achilles will be reattached with lateral and medial suture anchors (just distal to interference screw in FHL patients).

    Procedure: Achilles decompression and debridement with FHL transfer

Interventions

  • ProcedureAchilles decompression & debridement

    Surgical intervention

  • ProcedureAchilles decompression and debridement with FHL transfer

    surgical intervention

06

What researchers measure

Primary outcomes

  1. ankle plantar flexion strength measured using a handheld dynamometer

    Time frame: pre-operatively, 3 months, 6 months, and 1 year

Secondary outcomes

  1. American Orthopaedic Foot and Ankle Society(AOFAS) Ankle-Hindfoot score

    Time frame: pre-operatively, 3 months, 6 months, and 1 year

  2. Visual analog pain scale (VAS)

    Time frame: pre-operatively, 3 months, 6 months, and 1 year

  3. Hallux plantarflexion strength using the dynamometer

    Time frame: pre-operatively, 3 months, 6 months, and 1 year

  4. Patient Satisfaction

    Time frame: 1 year

  5. Surgical complications

    Time frame: Date of Surgery

  6. Postoperative complications

    Time frame: 3 months, 6 months, and 1 year

07

Study locations

1 site
  • OrthoCarolina, PA
    Charlotte, North Carolina 28203, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 13, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00950053
Lead sponsor
OrthoCarolina Research Institute, Inc.
Responsible party
Sponsor
First posted
Jul 31, 2009
Start date
Dec 2008
Primary completion
Jun 2012
Completion
Jun 2012
Last update
Mar 13, 2013

Study contacts

Bruce E Cohen, MD
principal investigator · OrthoCarolina, P.A.

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion